Position in JNJ
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$6,633,950
+$186,845 QoQ
Shares Held
26,121
-1.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.55%
of 13F equity value
Holder Rank
#1,391
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Whitener Capital Management, Inc. holds $31,660,073 across 7 Drug Manufacturers - General names. JNJ ranks #2 (21.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
41,935 | $10,552,523 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
26,121 | $6,633,950 | |
| 3 | MRK |
Merck & Co., Inc.
|
45,420 | $5,836,470 | |
| 4 | LLY |
ELI LILLY & Co
|
2,960 | $3,550,313 | |
| 5 | AMGN |
Amgen Inc
|
5,665 | $2,051,409 | |
| 6 | PFE |
Pfizer Inc
|
82,959 | $1,997,652 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
8,214 | $1,037,756 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,633,950 | 26,121 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $6,447,105 | 26,375 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $5,487,693 | 26,517 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $4,766,221 | 25,705 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $3,406,936 | 22,304 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $3,507,184 | 21,148 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $2,886,325 | 19,958 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $3,496,606 | 21,576 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $3,294,738 | 22,542 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $3,465,626 | 21,908 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $3,518,342 | 22,447 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $3,855,279 | 24,753 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $4,148,427 | 25,063 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $3,967,380 | 25,596 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $4,434,974 | 25,106 | Shares | Sole | 2023-03-01 | |
| 2022-09-30 | $3,971,608 | 24,312 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $4,329,291 | 24,389 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $4,355,250 | 24,574 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $4,279,658 | 25,017 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,623,898 | 22,439 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,993,791 | 24,243 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,867,648 | 23,533 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $3,531,449 | 22,439 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $3,417,391 | 22,954 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $4,146,475 | 29,485 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $3,813,522 | 29,082 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||